Clinical Trial Update: Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating autologous gamma delta T cells targeting PSCA in metastatic castration-resistant prostate cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Autologous gamma delta T cells targeting PSCA (autologous gamma delta T cells targeting PSCA)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1 | Status: RECRUITING